Minapharm Pty Ltd

All Australian companiesProfessional, scientific and technical activitiesMinapharm Pty Ltd

Quantity surveying activities / Veterinary activities / Market research and public opinion polling / Tax consultancy

Minapharm Pty Ltd: address, phone, fax, email, site

Address: NSW 2035

Phone: +61-06-8364-9686

Fax: +61-06-8364-9686

E-mail: n\a

Site:

Owner / Director / Manager Minapharm Pty Ltd: n\a

Work hour and Schedule:

Find error or want add more details informations for "Minapharm Pty Ltd"? - Contact us!

Minapharm Pty Ltd full data: finance, accounts, vacancies. Download bank accounts, tenders, credit history, taxes and fees Minapharm Pty Ltd.

Registration data Minapharm Pty Ltd

Australian Company Number: 120497083

Status: Registered

Registration date: July 3, 2006

Type: Australian proprietary company

Australian Business Number: 23120497083

Class: Limited by Share

Subclass: Proprietary other

Get full report form global database AU for Minapharm Pty Ltd

Job in Minapharm Pty Ltd vacancies. Career and practice on Minapharm Pty Ltd. Working and traineeship

Now on Minapharm Pty Ltd all vacancies is closed.

Responds for Minapharm Pty Ltd on FaceBook

Read all comments for Minapharm Pty Ltd. Leave a respond Minapharm Pty Ltd in social networks. Minapharm Pty Ltd on Facebook and Google+

Address Minapharm Pty Ltd on google map

Other related companies as Minapharm Pty Ltd: Bannerhive Pty. Ltd. | Gardi Investments Pty Ltd | Glassenbury Pty Ltd | Miadda Corporation Pty Ltd | Azzero Group Pty Limited

Minapharm Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2035 since 2008-04-10 the company is, as the updated on 2014-10-22 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2008-04-10 until 2014-09-29. Known company numbers for Minapharm Pty Ltd are as follows: ACN - 120497083, Australian Business Number - 23120497083. Minapharm Pty Ltd has been the company name since 2008-03-25. AUBiz found 0 trademarks that reference the abovementioned company.